Françoise Durrieu is an expert in Hematology at Institut Bergonié (France). Françoise Durrieu has authored 13 publications, the most recent in 2023. SLR score: 31 (community average: 125). How the SLR is computed.

LeadR Profile

Françoise Durrieu Institut Bergonié France
31 ScienceLeadR Reputation 31
Network Map

Hematology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2011 - 2023

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 13

Citations

Citations: 133 1st author: 1 Last author: 1 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Understanding the drivers of patient satisfaction with home health care services: An empirical study of two care pathways.
PMID 37491716 — health planning, patient satisfaction, home care services
Int J Health Plann Manage20232
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.
PMID 37297553 — environmental exposure, sars-cov-2, vaccines, antibodies, neoplasms, respect, covid-19, prevalence, severe acute respiratory syndrome-related coronavirus, infections, vaccination hesitancy
Int J Environ Res Public Health20230
Evaluation of the WBC-differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institution.
PMID 36351659 — cells, flow cytometry, automation, laboratory, monocytes, hematology, work, landslides
Int J Lab Hematol20221
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
PMID 33988316 — protein-tyrosine kinases, therapeutics, neoplasms, leukemia, myeloid, chronic-phase
Cancer Med20216
A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.
PMID 32043283 — cost savings, leukemia, leukemia, myeloid, therapeutics, leukemia, myelogenous, chronic, bcr-abl positive
Br J Haematol20202

LeadR Networks

Main global connection map